Would you recommend the following article to a politician, an athlete, a business executive, or a scientist?

Second Merck drug faces inquiry WALL STREET analysts last night said a second experimental pain killer under development by Merck, the American drugs maker, could be delayed until 2007, after regulators asked for more information on the medicines safety.
